In recent investment developments, Duquesne Family Office made notable acquisitions in Q1 2026, purchasing 195,955 shares of Broadcom and 1.89 million shares of Caris Life Sciences, signaling strong confidence in tech and life sciences sectors. The firm also exited positions in Alphabet and Cogent Biosciences and reduced stakes in Amazon, reflecting a cautious strategy in a volatile market. Additionally, Duquesne increased its holdings in STMicroelectronics and Natera, indicating optimism in their growth potential.
Other contributors in the market included D1 Capital, which significantly reduced its stake in Meta while bolstering its investment in Amazon despite its stock decline, and Trump, who purchased substantial shares of Palantir, demonstrating confidence in AI technologies. The broader stock market appears to be recovering, with the S&P 500 on track for its seventh consecutive positive week, although rising bond yields and oil prices present concerns for future consumer spending and corporate investments.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://intellectia.ai/news/stock/druckenmillers-duquesne-office-invests-in-broadcom-and-caris-life-sciences
